BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS

• Main Authors: V. B. Vasilyuk (Author), A. Yu. Boroduleva (Author), P. D. Sobolev (Author), A. G. Nikiforova (Author), V. G. Mozgovaya (Author), O. V. Filon (Author), A. V. Zinkovskaya (Author), V. G. Ignatiev (Author), M. Yu. Samsonov (Author), I. S. Kozlova (Author), E. K. Khanonina (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Molnupiravir is one of the drugs for the etiotropic therapy of a new coronavirus infection COVID-19. It has confirmed its clinical efficacy in the treatment of patients with mild and moderate COVID-19, including those who are at high risk of progressing to severe disease.The aim of the study was to...